Literature DB >> 8487545

Reactivity to alcohol-related cues in heavy and light drinkers.

J D Greeley1, W Swift, J Prescott, N Heather.   

Abstract

Physiological responses and self-reported desire for alcohol were compared in heavy (n = 21) and light (n = 29) drinkers under each of two cue conditions. The cues were presented in a counterbalanced order and consisted of the sight, smell and taste of the subject's preferred alcoholic beverage (alcohol cue) and of a nonalcoholic lemon-flavored drink (neutral cue). Heavy drinkers showed a significant linear increase in reported desire for alcohol over time in the presence of the alcohol cue. This persistent increase in desire for alcohol seen in heavy drinkers contrasted with the initial increase shown by light drinkers which dissipated over time. Neither group showed any significant change in desire for alcohol when presented with the neutral cue. Heavy drinkers showed lower levels of skin conductance than light drinkers and all subjects showed changes in heart rate during exposure to both cues. Heart rate was affected differentially in the two groups of drinkers but only when the alcohol cue was presented first. Neither blood pressure nor stress and arousal levels changed significantly from pre- to post-cue presentations. The findings of this study have implications for understanding the nature and time course of cue-elicited desire for alcohol and its potential role in the development and treatment of alcohol dependence.

Entities:  

Mesh:

Year:  1993        PMID: 8487545     DOI: 10.15288/jsa.1993.54.359

Source DB:  PubMed          Journal:  J Stud Alcohol        ISSN: 0096-882X


  22 in total

Review 1.  The development of acamprosate as a treatment against alcohol relapse.

Authors:  Peter R Kufahl; Lucas R Watterson; M Foster Olive
Journal:  Expert Opin Drug Discov       Date:  2014-09-26       Impact factor: 6.098

Review 2.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

Review 3.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 4.  Modeling relapse situations in the human laboratory.

Authors:  Rajita Sinha
Journal:  Curr Top Behav Neurosci       Date:  2013

5.  Differences in extinction of cue-maintained conditioned responses associated with self-administration: alcohol versus a nonalcoholic reinforcer.

Authors:  August F Holtyn; Barbara J Kaminski; Gary S Wand; Elise M Weerts
Journal:  Alcohol Clin Exp Res       Date:  2014-10-21       Impact factor: 3.455

6.  Nicotine-induced enhancement of Pavlovian alcohol-seeking behavior in rats.

Authors:  Jean-Marie N Maddux; Nadia Chaudhri
Journal:  Psychopharmacology (Berl)       Date:  2016-12-23       Impact factor: 4.530

7.  Specificity of P3 event-related potential reactivity to alcohol cues in individuals low in alcohol sensitivity.

Authors:  Bruce D Bartholow; Sarah A Lust; Sarah L Tragesser
Journal:  Psychol Addict Behav       Date:  2010-06

Review 8.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

9.  Stimulus conditioned to foot-shock stress reinstates alcohol-seeking behavior in an animal model of relapse.

Authors:  Xiu Liu; Friedbert Weiss
Journal:  Psychopharmacology (Berl)       Date:  2002-11-22       Impact factor: 4.530

10.  Enhanced sensitivity to stress and drug/alcohol craving in abstinent cocaine-dependent individuals compared to social drinkers.

Authors:  Helen C Fox; Kwang-Ik A Hong; Kristen Siedlarz; Rajita Sinha
Journal:  Neuropsychopharmacology       Date:  2007-06-13       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.